Company

About Us

Engineering Innovation Through Biotechnology

We use biotechnology to tackle complex challenges.

At INMET, we are a company with extensive experience in metabolic engineering. Through technologies like synthetic biology, precision fermentation, metabolomics, and protein engineering, we design and optimize microorganisms capable of producing high-value biomolecules. Our approach combines innovation and scalability to take each development from lab to industrial production.

We collaborate with established companies, biotech startups, and academic institutions, offering tailored services ranging from genetic engineering of microorganisms to pilot-scale fermentation in a 1,000-liter bioreactor. As part of the Grupo Bioceres and strategic partners of Ledesmawe drive innovative developments, such as our own biopolymer project.

At INMET, we are more than a service provider —we are your R&D extension. Discover how our technology platforms can boost your innovation.

Our mission is to drive biotechnological innovation through customized solutions and cutting-edge production processes, assisting companies, startups, and academics in transforming their ideas into scalable and sustainable realities.

Founding Story

Inmet was founded in 2011 as an initiative of CONICET researchers Diego de Mendoza and Gustavo Schujman, together with INDEAR. Dr. Diego de Mendoza is a Senior Researcher at CONICET at the Institute of Molecular and Cellular Biology of Rosario (IBR) and an Honorary Professor at the National University of Rosario. He was co-founder and first Director of IBR, and founder of the Basic Microbiology division at the Faculty of Biochemical and Pharmaceutical Sciences. He has been an International Researcher at the Howard Hughes Medical Institute (HHMI), a recipient of the Guggenheim Fellowship, the Humboldt Award from the Alexander von Humboldt Foundation, and was named Researcher of the Argentine Nation in 2017 by the Office of the President.

Dr. de Mendoza’s research program focuses on the study of lipid metabolism in model organisms. His lab has elucidated regulatory mechanisms that control the quantity and quality of lipids synthesized by the bacterium Bacillus subtilis, which are key to using this microorganism as a biofactory. The lab also studies sterol and fatty acid metabolism in nematodes and their potential applications in human health and agriculture.

Founding Story